Transdermal Patches: Global Markets

Transdermal Patches: Global Markets

Report Scope:

This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.

Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.

This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.

Report Includes:

122 data tables and 53 additional tables

An overview of the global transdermal patches market

Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027

Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region

Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast

Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies

Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system

Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis

Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.

Companies Mentioned

ABBVIE INC.
ALVOGEN
Amneal Pharmaceuticals, Inc.
Bausch Health Companies Inc.
BAYER HEALTHCARE PHARMACEUTICALS
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRÜNENTHAL GMBH
HISAMITSU PHARMACEUTICAL CO., INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
Perrigo Company plc
PURDUE PHARMA L.P.
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.